Basmisanil
CAS: 1159600-41-5
Ref. 3D-FD158569
10mg | Descatalogado | ||
25mg | Descatalogado | ||
50mg | Descatalogado | ||
100mg | Descatalogado | ||
250mg | Descatalogado |
Información del producto
- 1,1-Dioxo-4-thiomorpholinyl)[6-[[3-(4-fluorophenyl)-5-methylisoxazol-4-yl]methoxy]pyridin-3-yl]methanone
Basmisanil is an experimental drug that has shown efficacy in treating psychotic disorders. It is a GABA-A antagonist, which blocks the binding of gamma-aminobutyric acid (GABA) to its receptors. Basmisanil has been shown to inhibit protein synthesis in vitro and also prevents the growth factor from binding with its receptor, thereby blocking the neurotrophic effects. Basmisanil has been shown to be chemically stable and is not toxic to cells, making it a good candidate for use as a diagnostic agent and/or treatment of autoimmune diseases.